Client: U.K Department of Health and Social Care
Duration: 2019-2025
Region: Asia and the Pacific
Country: Indonesia
Solutions: Global Health
The Fleming Fund is a U.K. Department of Health and Social Care program to help low- and middle-income countries fight antimicrobial resistance (AMR).
DAI’s Fleming Fund program in Indonesia is a collaboration with the Indonesian government to strengthen systems using a “One Health” approach—a multisectoral approach to complex health problems that reaches across human health, animal health, and environment sectors. As global leaders in the approach, the DAI team is helping incorporate One Health across program interventions, supporting Indonesia in becoming a leader in combating AMR and a model for better management of antimicrobials in human and animal populations.
After the successful completion of Phase I, DAI was awarded the Fleming Fund Phase II Indonesia grant to continue to improve Indonesia’s ability to diagnose drug-resistant bacteria, generate data, and strengthen surveillance to inform policy and practice at national and international levels.
Phase I focused on enhancing laboratory infrastructure, strengthening human resources and workforce reforms, strengthening AMR and antimicrobial use surveillance systems, building foundations for AMR surveillance data, and promoting rational use of antimicrobial medicines. Phase II will pursue intermediate outcomes relating to the quality data produced for antimicrobial resistance/consumption/use and burden, quality data analysis conducted, and quality data analysis shared with decision-makers, with the aim of progressing towards the long-term outcome of sustainable investment in country and global levels to counter AMR.
This 22-month Phase II initiative, administered through Mott Macdonald and led by DAI, includes a consortium comprising the Liverpool School of Tropical Medicine, Health Security Partners, Prevalensi, and the Koperasi Jasa Institut Riset Eijkman.
RELATED CONTENT:
The Integrated Pharmaceutical and Supply Chain Technical Assistance Activity works to ensure more sustainable access to—and appropriate use of—quality-assured and affordable health commodities in Kenya by supporting the development of an increasingly resilient and mature supply chain system and pharmaceutical regulatory services.
Read More